Fig. 3

Incidences of relapse, NRM, and off-immunosuppressants, and probabilities of OS, PFS and GRFS in the ATG and PTCy groups. The cumulative incidences of relapse (a), NRM (b), and off-immunosuppressants (c), and the probabilities of OS (d), PFS (e), and GRFS (f) in the ATG (solid lines) and non-ATG (dashed lines) groups.